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Background/Aim: The neurological effects of internal carotid artery (ICA) occlusion vary between
patients. The authors investigated whether the severity of symptoms in a large group of patients with
ipsilateral or/and contralateral ICA occlusion at presentation with ocular or cerebral ischaemic symptoms
could be explained by patency of other extra or intracranial arteries to act as collateral pathways.
Methods: The authors prospectively identified all patients (n = 2881) with stroke, cerebral transient
ischaemic attack (TIA), retinal artery occlusion (RAO), and amaurosis fugax (AFx) presenting to our
hospital over five years, obtained detailed history and examination, and examined the intra and
extracranial arteries with carotid and colour-power transcranial Doppler ultrasound. For this analysis, all
those with intracranial haemorrhage on brain imaging and cerebral events without brain imaging were
excluded.
Results: Among 2228/2397 patients with brain imaging (1713 ischaemic strokes, 401 cerebral TIAs, 193
AFx, and 90 RAO) who underwent carotid Doppler, 195 (9%) had ICA occlusion. Among those patients
with cortical events, disease in potential collateral arteries (contralateral ICA, external carotid, ipsilateral
or contralateral vertebral or intracranial arteries) was equally distributed among patients with severe and
mild ischaemic presenting symptoms.
Conclusion: The authors found no evidence that the clinical presentation associated with an ICA occlusion
was related to patency of other extra or intracranial arteries to act as collateral pathways. Further work is
required to investigate what determines the clinical effects of ICA occlusion.
P
eople who occlude their internal carotid artery (ICA)
may do so asymptomatically, or may experience neuro-
logical effects ranging from transient ischaemic attack
(TIA) to major disabling stroke.1 The reason for such
variation is uncertain, but one possible explanation is that
severe strokes occur in patients whose potential collateral
pathways were poor because of disease in, or developmental
absence of, other extra or intracranial arteries supplying the
brain.
Although there are several studies on ICA occlusion and
type of symptoms, few have tried to determine why some
patients present with severe symptoms and others do not.
The few previous studies that do relate symptoms to
intracranial flow were small,2–5 or only included TIA or minor
stroke, not all stroke severities.2–4 Two3 5 found an association
between symptoms and collateral flow in mild stroke and
two did not.2 4
Other studies were biased because they only included dead
patients6 or those undergoing angiography.7 8 One study
related the extent of cerebral infarction on brain imaging
(but not symptoms) to collateral flow.9 Some studies
investigated the risk of recurrent stroke in longstanding
ICA occlusion.10–12 One of these studies found that recurrent
stroke distal to a symptomatic ICA occlusion was associated
with increased volume flow in collaterals (contralateral ICA),
counterintuitive to the hypothesis that better collateral flow
is protective.11 Previous studies mainly examined intracranial
collateral pathways2–10 and only two looked at collateral
potential in the extracranial arteries.11 12
The failure of previous studies to find any consistent
association between collaterals and symptoms may be
because they generally included patients with only mild
symptoms. Therefore, our aim was to explore the influence of
the collateral pathways on the nature and severity of
symptoms in a large, consecutive, hospital based series of
patients presenting with ICA occlusion and new cerebral or
ocular ischaemic symptoms. We hypothesised that patients
with ICA occlusion at presentation with severe stroke
symptoms were more likely to have disease in other extra
or intracranial arteries, impairing their function as collaterals.
METHODS
From November 1994 to April 1999, we prospectively
identified all patients (including first and recurrent events)
presenting to our stroke service with acute stroke, cerebral
transient ischaemic attack (TIA), amaurosis fugax (AFx), and
retinal artery occlusion (RAO). We recorded whether there
was a history of prior stroke or TIA.
A stroke physician examined the patient as soon as
possible following onset of symptoms. Those with acute
stroke were classified clinically according to the Oxfordshire
Community Stroke Project (OCSP).13 Cerebral TIAs were
categorised as posterior circulation or anterior circulation,
then the anterior circulation TIAs were further divided into
lacunar or cortical TIAs according to the presence or absence
of cortical symptoms. RAO was defined as monocular visual
loss, partial or complete, lasting more than 24 hours likely to
be due to vascular disease of the retina. Brain imaging (CT or
Abbreviations: ACA, anterior cerebral artery; ACoA, anterior
communicating artery; AFx, amaurosis fugax; CCA, common carotid
artery; ECA, external carotid artery; ICA, internal carotid artery; LACI,
lacunar infarct; MCA, middle cerebral artery; OCSP, Oxfordshire
Community Stroke Project; PACI, partial anterior circulation infarct;
PCoA, posterior communication artery; POCI, posterior circulation
infarct; RAO, retinal artery occlusion; TACI, total anterior circulation
infarct; TIA, transient ischaemic attack.
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MRI) was done in patients with acute stroke, and when
clinically indicated in patients with cerebral TIA, RAO, and
AFx (for example, in patients with multiple or atypical
attacks) immediately after medical assessment, in order to
identify those with intracranial haemorrhage and stroke
‘‘mimics’’. We classified infarct site and size using a validated
stroke imaging scoring system.14 15
Patients underwent carotid colour Doppler ultrasound
imaging (Acuson 128XP 10V, 7 MHz multifrequency probe
(Siemens, Germany)) by a consultant neuroradiologist or an
experienced neuroradiographer, blinded, where possible, to
the type and the side of clinical symptoms immediately after
medical assessment. Presence and severity of stenosis in both
ICAs, external carotid arteries (ECAs), and common carotid
arteries (CCAs) were measured using velocity criteria and
lesion appearance.16 Complete ICA occlusion was diagnosed if
there was no colour flow in the lumen of the vessel and no
detectable Doppler signal. Flow direction (orthograde or
retrograde) and velocity in the vertebral arteries was also
recorded. Occluded vertebral arteries were diagnosed when a
clear view of the vertebral canal was obtained but no flow
was detected.
The intracranial vessels: A1 segment of the anterior
cerebral artery (ACA), anterior communicating artery
(ACoA), posterior communicating artery (PCoA), middle
cerebral artery (MCA), P1 and P2 segments of posterior
cerebral artery, ophthalmic artery, intracranial portion of the
ICAs and basilar artery, were examined using colour power
transcranial Doppler by the same ultrasonographer at the
time of carotid imaging, in as many patients as possible. A
2 MHz probe was used for the trans-temporal and subocci-
pital approaches and a 7 MHz for the transorbital approach.
The ultrasonographer made a diagnosis of ‘‘normal’’,
‘‘reduced but still detectable flow’’, ‘‘occlusion’’, ‘‘hyperae-
mia’’, or ‘‘focal stenosis’’ using previously reported criteria.17
For patients with cortical brain events (that is, total
anterior circulation infarcts, TACIs, partial anterior circula-
tion infarcts, PACIs, and cortical TIAs) and an ipsilateral ICA
occlusion, we compared the severity of the clinical syndrome
with disease in the other extracranial arteries or patterns of
flow in the intracranial circulation. We also sought any
association between prior TIA or stroke and the severity of
current symptoms using x2 tests or x2 tests for trend. We
performed these analyses in two different ways: firstly, we
included those patients with no brain imaging; and then we
repeated the analyses after excluding patients with cerebral
symptoms (that is, stroke and cortical TIA) and no brain
imaging. Here we report results after the exclusion of patients
with cerebral symptoms and no brain imaging.
RESULTS
Patients
Between November 1994 to April 1999, 2881 patients with
stroke, cerebral TIA, RAO, or AFx were identified, of whom
2292 had CT or MR brain imaging (96% of strokes and 61% of
cerebral TIAs). 148 with intracerebral haemorrhage and 336
patients with cerebral symptoms and no brain imaging were
excluded. Of the remaining 2397 patients, there were 1713
ischaemic strokes, 401 cerebral TIAs, 193 AFx, and 90 RAO.
Of 2228 patients (93%) with carotid Doppler imaging, 195
(9%) had ICA occlusions (fig 1). Of the 195 patients with ICA
occlusions, 146 (75%) had an occlusion ipsilateral to the
brain or eye lesion only, 36 (18%) had a contralateral
occlusion only, eight had bilateral occlusions; and a further
20
18
14
16
12
8
10
6
4
0
2
Po
ste
rio
r T
IA
Syndrome
%
 P
at
ie
nt
s 
w
ith
 s
yn
dr
om
e 
w
ho
 h
av
e 
IC
A
 o
cc
lu
si
on
La
cu
na
r T
IA
PO
CI
LA
CI
Co
rtic
al 
TIAAF
x
RA
O
PA
CI
TA
CI
Ipsilateral
Contralateral
Figure 1 Proportion of patients with ipsilateral or contralateral ICA
occlusion by type of presentation with cerebral or retinal ischaemic
syndromes.
Table 1 Disease of the contralateral internal carotid artery, ipsilateral or contralateral
external carotid arteries, and vertebral arteries in patients with cortical symptoms and an
ipsilateral ICA occlusion
TACI and ipsilateral
ICA occlusion
(n = 22)
PACI and ipsilateral
ICA occlusion
(n = 70)
Cortical TIA and
ipsilateral ICA
occlusion (n = 14)
Other patients with
any ICA occlusion
(n = 89)
Contralateral ICA
disease >70% stenosis,
n (%)
5 (23%) 20 (29%) 5 (36%) 47 (53%)
Any ipsilateral ECA
stenosis, n (%)
10 (45%) 29 (41%) 5 (36%) 42 (47%)
Any contralateral ECA
stenosis, n (%)
7 (32%) 18 (26%) 4 (29%) 36 (40%)
Ipsilateral vertebral
artery occluded or
reduced flow, n (%)
1 (5%) 8 (11%) 0 (0%) 2 (2%)
Contralateral vertebral
artery occluded or
reduced flow, n (%)
1 (5%) 7 (10%) 0 (0%) 2 (2%)
ICA, internal carotid artery; ECA, external carotid artery.
Ipsilateral vertebral artery is on the same side of the neck as the ipsilateral ICA.
‘‘Other’’ includes the contralateral occlusions, and the RAO, AFx, LACI, lacunar TIA, POCI, and posterior
circulation TIA with ipsilateral occlusions.
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five occlusions were identified in patients with midline brain
lesions or bilateral lesions.
Most of the 7% who did not have carotid imaging had had
severe strokes and did not survive or were too ill to move for
imaging. As expected, ipsilateral ICA occlusion was most
common in patients with cortical and eye events and in those
with more severe symptoms (fig 1).
There was a history of prior TIA or stroke in 7/22 TACIs
(32%), 35/70 (50%) PACIs, and 8/14 (57%) cortical TIAs, but
the difference was not significant (x2 p = 0.33)
Extracranial disease
Among patients with cortical symptoms (TACI, PACI, and
cortical TIA) and ipsilateral ICA occlusion there was no
significant difference in the prevalence of contralateral ICA
disease (x2 for trend p = 0.4), ipsilateral external carotid
(ECA) disease (x2 for trend p = 0.6), contralateral ECA
disease (x2 for trend p = 0.8), or contralateral or ipsilateral
vertebral abnormalities between the three groups (table 1).
We repeated the analyses having excluded patients with
previous stroke (that is, those whose ICA occlusion may have
been symptomatic at some time in the past) but these data
did not change the results (data available on request).
Collateral flow patterns of intracranial vessels
We looked for trends in collateral flow patterns (table 2)
across patients with cortical symptoms (TACI, PACI, and
cortical TIA). There were no trends in the proportions of
patients with abnormal flow in the intracranial or ophthal-
mic artery circulation across the three groups with cortical
symptoms. The only hint of a difference was that the
ipsilateral MCA flow was more often reduced among the
TACI and PACI than the cortical TIA patients, as one would
expect soon after stroke, consistent with an MCA occlusion
rather than indicating collateral flow. Note that the
commonest finding was for potential collateral channels,
for example the anterior or posterior communicating arteries,
to be ‘‘invisible’’ but as functioning collateral arteries are
usually large and readily visible, their invisibility indicates
that these arteries were unlikely to be functioning as
significant collaterals. Furthermore, although we have not
performed formal statistical analysis due to the small
numbers, there is no hint of any trend in potential collateral
pathways across the three groups.
When we included the strokes and cortical TIAs with no
brain imaging in the analyses, the results were very similar
(full results available on request).
Table 2 Transcranial Doppler data from patients with an ipsilateral internal carotid artery occlusion, divided according to
presenting syndromes
Artery
TACI and ipsilateral
ICA occlusion (n = 22)
PACI and ipsilateral
ICA occlusion (n = 70)
Cortical TIA and
ipsilateral ICA
occlusion (n = 14)
Other patients with
any ICA occlusion
(n = 89)
Number of patients in whom TCD was attempted 19 57 12 74
Ipsilateral bone window adequate 16 30 8 50
Basilar artery Reduced flow 0 (0%) 2 (7%) 0 (0%) 3 (6%)
Invisible 7 (44%) 15 (50%) 2 (25%) 21 (42%)
Normal 9 (56%) 13 (43%) 6 (75%) 26 (52%)
Ipsilateral ACA (A1
direction)
Correct 2 (13%) 3 (10%) 1 (12%) 18 (36%)
Reversed 8 (50%) 12 (40%) 4 (50%) 10 (20%)
Invisible 6 (32%) 15 (50%) 3 (38%) 22 (44%)
Ipsilateral MCA Abnormal 13 (81%) 23 (77%) 4 (50%) 17 (34%)
Normal 3 (19%) 7 (23%) 4 (50%) 33 (66%)
Ipsilateral PCA (P1
direction)
Correct 12 (75%) 22 (73%) 7 (88%) 42 (84%)
Reversed 0 (0%) 0 (0%) 0 (0%) 1 (2%)
Invisible 4 (25%) 8 (27%) 1 (12%) 7 (14%)
Ipsilateral PCoA Anterior to posterior 1 (6%) 0 (0%) 0 (0%) 2 (4%)
Posterior to anterior 2 (13%) 7 (23%) 2 (25%) 10 (20%)
Invisible 13 (81%) 23 (77%) 6 (75%) 38 (76%)
Ipsilateral ophthalmic
artery
Correct 7 (44%) 13 (43%) 3 (38%) 36 (72%)
Reversed 6 (37%) 16 (53%) 4 (50%) 14 (28%)
Invisible 3 (19%) 1 (3%) 1 (12%) 0 (0%)
ACoA Right to left 4 (25%) 2 (7%) 2 (25%) 8 (16%)
Left to right 1 (6%) 5 (17%) 1 (12%) 9 (18%)
Balanced 2 (13%) 1 (3%) 0 (0%) 1 (2%)
Invisible 9 (57%) 22 (73%) 5 (62%) 32 (64%)
Contralateral bone window adequate 16 36 7 50
Contralateral ACA (A1
direction)
Correct 12 (75%) 22 (61%) 7 (100%) 22 (44%)
Reversed 0 (0%) 0 (0%) 0 (0%) 11 (22%)
Invisible 4 (25%) 14 (39%) 0 (0%) 17 (34%)
Contralateral MCA Abnormal 3 (19%) 8 (22%) 1 (14%) 13 (26%)
Normal 13 (81%) 28 (78%) 6 (86%) 37 (74%)
Contralateral PCA (P1
direction)
Correct 11 (69%) 24 (67%) 6 (86%) 41 (82%)
Reversed 0 (0%) 0 (0%) 0 (0%) 1 (2%)
Invisible 5 (31%) 12 (33%) 1 (14%) 8 (16%)
Contralateral PCoA Anterior to posterior 2 (13%) 1 (3%) 0 (0%) 5 (10%)
Posterior to anterior 0 (0%) 2 (6%) 1 (14%) 6 (12%)
Invisible 14 (87%) 33 (92%) 6 (86%) 39 (78%)
Contralateral ophthalmic
artery
Correct 12 (75%) 33 (92%) 7 (100%) 40 (80%)
Reversed 1 (6%) 2 (6%) 0 (0%) 9 (18%)
Invisible 3 (19%) 1 (3%) 0 (0%) 1 (2%)
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DISCUSSION
This large study of 2450 patients presenting with new
neurological symptoms (ranging from transient symptoms
to major disabling stroke) found that in those with ipsilateral
ICA occlusion, there was no association between adequacy of
potential collateral pathways and the severity of stroke
symptoms. Although there is an extensive literature on ICA
occlusion, few studies have investigated whether collaterals
determine the severity and type of symptoms at the time of
ICA occlusion, and most of these were either small and/or
recruited patients with TIA or minor strokes.2–5 The strength
of our study was that we prospectively studied a large cohort
of patients presenting to a broad based hospital stroke
service, including a substantial number of patients with
severe as well as mild strokes, TIAs, and retinal symptoms.
Almost all underwent carotid imaging, and of those with
ipsilateral ICA occlusion, most had TCD performed, resulting
in a complete data set in the majority of patients.
There were some limitations to our study. Our stroke
registry did not include asymptomatic people with an ICA
occlusion (who might be expected to have the best collateral
flow if our original hypothesis was correct)—the registry only
recorded patients with symptoms. Also, we could not reliably
distinguish ICA occlusion occurring at the time of the
patients’ presenting symptoms from those which may have
occurred some time previously. However, even if the
occlusion were longstanding, one might expect the severity
of the presenting symptoms to relate to the adequacy of
collaterals and therefore still have expected to observe a
relationship between flow in collaterals and severity of
symptoms. The group most likely to miss having carotid
and transcranial Doppler studies (7% of 2397 patients) were
the TACIs or POCIs who were more likely to die or be
considered too ill for imaging. However, because we found no
association between potential sources of intracranial collat-
eral flow and the different patient groups, the exclusion of
these few severe strokes probably did not influence our
results. We used ultrasound rather than other imaging
techniques because it is non-invasive, quick to perform, far
more accessible than any other form of carotid imaging, and
tolerated by the majority of patients, even those who are very
ill. However, the intracranial vessels may be inaccessible in a
substantial number of patients, and pathology in the
intracranial internal carotid artery and basilar artery may
be insufficiently evaluated by TCD.18 The accuracy of duplex
Doppler compared with angiography is high for carotid
disease,19 so even if we misclassified a few patients with
severe ICA stenosis as ICA occlusion, this would not have
affected the overall results. We did not examine cerebral
perfusion patterns with PET or perfusion MR as it would not
have been practical to perform these in such a large group of
patients (including severe strokes) and would have restricted
and biased our recruitment.
Therefore we still do not know why some patients with ICA
occlusion develop severe stroke symptoms and others remain
asymptomatic. The underlying cause of ICA occlusion (that
is, cardioembolic or thrombus on atheroma) may influence
the clinical effects of ICA occlusion by affecting the rate at
which collateral vessels may develop.20 Old cannot be
distinguished from new ICA occlusions reliably on Doppler
imaging, but the few postmortem studies of patients dying
from ischaemic stroke show that the aetiology is generally
fresh thrombus on pre-existing atheroma20 21 and sudden
embolic occlusion in the neck of a previously normal ICA is
unusual. There are some data to support the notion that prior
stroke or TIA may protect against the effects of sudden ICA
occlusion by ‘‘ischaemic pre-conditioning’’,22 23 and some that
do not.24 Our data provide no conclusive evidence either way.
However, if prior TIA and stroke are protective, this could
relate to use of antiplatelet drugs rather than changes in
cerebrovascular haemodynamics, because patients with pre-
vious TIA or minor stroke would be more likely to be taking
aspirin at the time of their index stroke.
Further work is required to determine what causes some
ICA occlusions to cause severe strokes, but our data suggest
that it does not seem to be a simple ‘‘plumbing’’ problem. It
might be helpful to develop a technique for distinguishing old
from new occlusions. Comparison of symptoms in presumed
atherosclerotic occlusion (progressive occlusion, with time to
develop collaterals) with presumed cardioembolic occlusion
might help to determine whether the collateral vessels are
important in determining the clinical effects of occlusion.
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